Squarepoint Ops LLC Durect Corp Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $15,258 - $22,209	-16,954 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.61 $20,514 - $27,295	16,954 New	16,954 $22,000
Q2 2021 Aug 16, 2021	SELL	$1.6 - $2.02 $51,593 - $65,136	-32,246 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.86 - $2.87 $275,722 - $425,443	-148,238 Reduced 82.13%	32,246 $64,000
Q4 2020 Feb 16, 2021	BUY	$1.65 - $2.43 $138,278 - $203,646	83,805 Added 86.68%	180,484 $374,000
Q3 2020 Nov 16, 2020	SELL	$1.6 - $2.35 $77,632 - $114,022	-48,520 Reduced 33.42%	96,679 $165,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $2.76 $193,114 - $400,749	145,199 New	145,199 $337,000
Q1 2020 May 15, 2020	SELL	$0.97 - $2.85 $74,992 - $220,339	-77,312 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.69 - $3.8 $80,459 - $180,914	47,609 Added 160.28%	77,312 $294,000
Q3 2019 Nov 14, 2019	BUY	$0.61 - $2.21 $18,118 - $65,643	29,703 New	29,703 $55,000
Q4 2017 Feb 14, 2018	SELL	$0.78 - $2.1 $124,566 - $335,370	-159,700 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.55 - $1.82 $247,535 - $290,654	159,700	159,700 $283,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $223M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.